[Diabetics' life is about one third shorter. So you improve the prognosis of these high-risk patients].
Stiefelhagen
Peter
P
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003327:Coronary Disease / Q000150:complications* / Q000628:therapy; D048909:Diabetes Complications / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000401:mortality*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance; D009203:Myocardial Infarction / Q000401:mortality* / Q000517:prevention & control; D011322:Primary Prevention; D011379:Prognosis; D012307:Risk Factors; D013997:Time Factors
D000959:Antihypertensive Agents; D000960:Hypolipidemic Agents